BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11117153)

  • 1. MMPI-2 in the inpatient assessment of women with eating disorders.
    Cumella EJ; Wall AD; Kerr-Almeida N
    J Pers Assess; 2000 Dec; 75(3):387-403. PubMed ID: 11117153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMPI-2 profiles of women with eating disorders in a Dutch day treatment sample.
    Exterkate CC; Bakker-Brehm DT; de Jong CA
    J Pers Assess; 2007 Apr; 88(2):178-86. PubMed ID: 17437383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent validity of alternative MMPI-2 personality disorder scales.
    Hicklin J; Widiger TA
    J Pers Assess; 2000 Dec; 75(3):502-18. PubMed ID: 11117160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the MMPI-2 in the outpatient assessment of women with Anorexia Nervosa or Bulimia Nervosa.
    Pryor T; Wiederman MW
    J Pers Assess; 1996 Apr; 66(2):363-73. PubMed ID: 8869577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMPI-A in the inpatient assessment of adolescents with eating disorders.
    Cumella EJ; Wall AD; Kerr-Almeida N
    J Pers Assess; 1999 Aug; 73(1):31-44. PubMed ID: 10497800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An examination of three sets of MMPI-2 personality disorder scales.
    Jones A
    J Pers Disord; 2005 Aug; 19(4):370-85. PubMed ID: 16178680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting DMS-IV cluster B personality disorder criteria from MMPI-2 and Rorschach data: a test of incremental validity.
    Blais MA; Hilsenroth MJ; Castlebury F; Fowler JC; Baity MR
    J Pers Assess; 2001 Feb; 76(1):150-68. PubMed ID: 11206295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of the substance abuse scales of the MMPI-2 in a college student sample.
    Svanum S; McGrew J; Ehrmann L
    J Pers Assess; 1994 Jun; 62(3):427-39. PubMed ID: 8027909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the MMPI-2 in assessing gender dysphoric patients.
    Miach PP; Berah EF; Butcher JN; Rouse S
    J Pers Assess; 2000 Oct; 75(2):268-79. PubMed ID: 11020144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing depression with the MMPI and MMPI-2.
    Gross K; Keyes MD; Greene RL
    J Pers Assess; 2000 Dec; 75(3):464-77. PubMed ID: 11117157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximal measurement or meaningful measurement: the interpretive challenges of the MMPI-2 Restructured Clinical (RC) Scales.
    Caldwell AB
    J Pers Assess; 2006 Oct; 87(2):193-201. PubMed ID: 16972823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of MMPI-A items in discriminating between normative and clinical samples.
    Archer RP; Handel RW; Lynch KD
    J Pers Assess; 2001 Dec; 77(3):420-35. PubMed ID: 11781030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MMPI-2 in PerĂº: a normative study.
    Scott RL; Pampa WM
    J Pers Assess; 2000 Feb; 74(1):95-105. PubMed ID: 10779935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MMPI and MMPI-2 in an outpatient sample: comparisons of code types, validity scales, and clinical scales.
    Edwards DW; Morrison TL; Weissman HN
    J Pers Assess; 1993 Aug; 61(1):1-18. PubMed ID: 8377095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Eating Attitudes Test: validation with DSM-IV eating disorder criteria.
    Mintz LB; O'Halloran MS
    J Pers Assess; 2000 Jun; 74(3):489-503. PubMed ID: 10900574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary validation of the MMPI-A for a male delinquent sample: an investigation of clinical correlates and discriminant validity.
    Cashel ML; Rogers R; Sewell KW; Holliman NB
    J Pers Assess; 1998 Aug; 71(1):49-69. PubMed ID: 9807230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating psychotic patients from nonpsychotic patients with the MMPI-2 and Rorschach.
    Dao TK; Prevatt F; Horne HL
    J Pers Assess; 2008 Jan; 90(1):93-101. PubMed ID: 18444100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of MMPI-2 and MMPI clinical scales and high-point scores among methadone maintenance clients.
    Husband SD; Iguchi MY
    J Pers Assess; 1995 Apr; 64(2):371-5. PubMed ID: 7722861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an Infrequency-Psychopathology scale for the MMPI-A: the Fp-A Scale.
    McGrath RE; Pogge DL; Stein LA; Graham JR; Zaccario M; Piacentini T
    J Pers Assess; 2000 Apr; 74(2):282-95. PubMed ID: 10879356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The deconstruction of the Hy Scale of MMPI-2: failure of RC3 in measuring somatic symptom expression.
    Butcher JN; Hamilton CK; Rouse SV; Cumella EJ
    J Pers Assess; 2006 Oct; 87(2):186-92. PubMed ID: 16972822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.